Search results
AstraZeneca's Covid-19 vaccine linked to fatal blood clotting disorder?
MSN News· 7 days agoThe PF4 antibodies in the classical adenoviral vector VITT and the adenovirus infection-associated...
Posts Claim Falsely That AstraZeneca Is Withdrawing Its COVID Vaccine Because of Blood Clots
The Dispatch via Yahoo News· 7 days agoThe vaccine was never used in the U.S. AstraZeneca’s COVID-19 vaccine—which uses viral vector...
AstraZeneca's COVID-19 Prevention Therapy Cuts Risk Of Infection In Patients With Weaker Immunity,...
Benzinga via Yahoo Finance· 7 days agoThursday, AstraZeneca Plc (NASDAQ:AZN) released high-level results from the SUPERNOVA Phase 3 COVID-...
‘Inhumane’: Utah mom slaps drug company with lawsuit after suffering COVID vaccine trial injuries
AOL· 6 days agoEXCLUSIVE: A Utah mother says she was left with "no choice" but to sue a pharmaceutical company on the basis of a breached contract that promised to provide compensation for injuries caused ...
Pfizer plans to cut costs by $1.5 billion as demand for COVID vaccine dwindles
Quartz· 17 hours agoPharma giant Pfizer announced Wednesday another cost-cutting initiative as the company struggles...
'I suffered a stroke after my AstraZeneca Covid vaccine'
Daily Express· 5 days agoAstraZeneca has since said that thrombocytopenia syndrome can be a “rare” side effect of the vaccine...
New Covid FLiRT variants spark concerns of a summer spike
CNBC· 1 day agoNew strains of Covid-19 are spreading globally, raising concerns among health professionals about a...
AstraZeneca targets $80 billion in total revenue by 2030 in 'post-Covid era'
CNBC· 2 days agoThe Astrazeneca logo is pictured at the World Artificial Intelligence Conference 2021 in Shanghai,...
AstraZeneca aims increase its annual revenue by 75% in its post-COVID era
Quartz· 2 days agoCambridge, U.K.-based pharmacuetical giant AstraZeneca announced an ambitious sales goal for the end of this decade, just as it pulls it COVID- ...
AstraZeneca’s Phase III Covid-19 antibody trial meets primary endpoints
Clinical Trials Arena via Yahoo Finance· 6 days agoA follow-up dose was administered around six months later. According to the findings, sipavibart...